BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 17179189)

  • 1. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion.
    Bubbar CD; Blackburn DF; Wilson MP; Wilson TW
    Ann Pharmacother; 2007 Jan; 41(1):129-32. PubMed ID: 17179189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination therapy with ACE inhibitors and angiotensin receptor antagonists].
    Kisters K
    Internist (Berl); 1999 Jun; 40(6):678-9. PubMed ID: 10420325
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing hypertension using combination therapy.
    Frank J
    Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients.
    Baer JT; Sauer WH; Berlin JA; Kimmel SE
    Am J Cardiol; 2004 Aug; 94(4):479-81. PubMed ID: 15325933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of angiotensin converting enzyme inhibition and angiotensin II receptor antagonists in hypertension.
    Conlin PR
    J Med Liban; 2000; 48(6):382-6. PubMed ID: 11503531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAS inhibition in hypertension.
    Ibrahim MM
    J Hum Hypertens; 2006 Feb; 20(2):101-8. PubMed ID: 16397519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic possibilities for the inhibition of the renin-angiotensin-aldosterone system].
    Abrahám G; Légrády P
    Orv Hetil; 2003 May; 144(18 Suppl 1):892-5. PubMed ID: 12785232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination therapy with angiotensin receptor blockers and ACE inhibitors - contra].
    Ritz E
    Dtsch Med Wochenschr; 2009 Nov; 134(45):2295. PubMed ID: 19876806
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors in the treatment of hypertension.
    Mancia G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S1-3. PubMed ID: 1725194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antihypertensive therapy using a combination of angiotensin 1 receptor inhibitors with angiotensin-converting enzyme inhibitors].
    Meyer GJ
    Dtsch Med Wochenschr; 1998 May; 123(21):681. PubMed ID: 9638097
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combination therapy with angiotensin receptor blockers and ACE inhibitors - pro].
    Zidek W
    Dtsch Med Wochenschr; 2009 Nov; 134(45):2294. PubMed ID: 19876805
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypertension 2007-2008].
    Chatzikyrkou C; Menne J; Haller H
    Med Klin (Munich); 2009 Aug; 104(8):614-21. PubMed ID: 19701732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertension in patients with diabetes].
    Poulsen PL; Hansen KW; Gaede PH; Rossing P
    Ugeskr Laeger; 2009 Jun; 171(24):2031-4. PubMed ID: 19523370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.
    Weir MR
    J Hum Hypertens; 2007 Oct; 21(10):770-9. PubMed ID: 17597800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension].
    Burnier M
    Drugs; 2002; 62 Spec No 1():21-9. PubMed ID: 12036386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The therapy of arterial hypertension: a comparison between ACE inhibitors and angiotensin-II-receptor antagonists].
    Rossi F; Mangrella M; Paternò E; Imperatore F; Capristo M; Imperatore C; Guarino A
    Clin Ter; 1996 Oct; 147(10):475-88. PubMed ID: 9264900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine arterial hypertension: therapeutic approach in clinical practice.
    Mazza A; Armigliato M; Zamboni S; Rempelou P; Rubello D; Pessina AC; Casiglia E
    Minerva Endocrinol; 2008 Dec; 33(4):297-312. PubMed ID: 18923367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug therapy for hypertension in hemodialysis patients.
    Hörl MP; Hörl WH
    Semin Dial; 2004; 17(4):288-94. PubMed ID: 15250920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.